The world you see depends upon the news you get. ®
Merz Aesthetics Announces FDA Approval of XEOMIN® (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines
by |
RALEIGH, N.C.,–(BUSINESS WIRE)–FDA Approval of XEOMIN® (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines
